智慧藥丸市場 - 成長，趨勢，及預測(2019年 - 2024年)

本報告提供全球智慧藥丸市場的相關調查，市場概況和成長要素、阻礙因素，各用途領域、疾病前兆、地區的市場分析，競爭情形，主要企業的簡介等資訊彙整。

目錄

第1章 簡介

• 研究成果
• 調查的前提條件
• 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

• 市場概況
• 市場成長要素
  • 微創設備的選擇增加
  • 消化器官疾病的發生率的增加
  • 技術進步
• 市場阻礙因素
  • 技術進步造成的成本增加
  • 潛在的健康上的風險
• 波特五力分析
  • 新加入廠商的威脅
  • 買主/消費者談判力
  • 供應商談判力
  • 替代產品的威脅
  • 產業的競爭

第5章 市場區隔

• 各用途領域
  • 膠囊內視鏡
  • 病患監測
  • 藥物輸送
• 各疾病前兆
  • 原因不明的消化道出血
  • 克隆氏症
  • 小腸腫瘤
  • 麩質過敏症
  • 遺傳性息肉病症候群
  • 神經病變
  • 其他
• 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 南美

第6章 競爭情形

• 企業簡介
  • Boston Scientific Corporation
  • GE Healthcare
  • Given Imaging Ltd
  • Microchips
  • Novartis AG
  • Olympus Corporation
  • Phillips
  • Pixie Scientific
  • Proteus Pharmaceuticals
  • Vitality

第7章 市場機會及今後趨勢

Market Overview

A smart drug delivery pill is controlled by electronics and has great flexibility and precise control in delivery location, release rate, and dose. At the same time, it can monitor the local GI environment, report measurements in real time, and be commanded by an operator to perform an action on demand. This type of performance is impossible with conventional oral drug forms. While there are myriad therapeutic implications, the system can also be viewed from the direction of a smart tool that can be employed to great advantage in drug development of more conventional oral drug products. A smart pill is a medical device with a small embedded electronic product such as a camera, sensors, or trackers. The increased need for convenient, minimally invasive devices and accurate therapeutic treatment strategies has led to an increased interest in research on smart pills.

Products include the Medtronic MiniMed, Insulet Omnipod, and Animas OneTouch Ping. These systems combine elements of a drug reservoir, insulin pump, blood glucose monitor, and handheld management device. Delivery of insulin is adapted to the patient's current blood glucose level and may be delivered on demand by the patient, for example at mealtime. Similar is the emerging area of wearable bolus injection devices.

Scope of the Report

As per the scope of the report, smart pills are ingestible medical devices consisting of elements, such as sensors, cameras, patches, and trackers that help in better diagnostics and monitoring. These unique devices can be easily swallowed and offer a non-invasive, thorough examination of the gastrointestinal (GI) tract.

Key Market Trends

Capsule Endoscopy is Expected to Hold Largest Share of Global Smart Pills Market, Over the forecast period

The most common so far is targeting the small bowel, it is seen as a gold standard if GI bleeding is suspected. Also, Currently, most hepatologists perform either upper endoscopy or capsule endoscopy for detecting and assessing the severity of esophageal varices. Different capsules enlarge the variety of utilization and diagnostics. Capsule Endoscopy has the largest share in the market as these smart pills are highly used to related disease to the GI Tract which includes Crohn's disease, obscure GI bleed, celiac disease, and small bowel tumors. Furthermore, increasing prevalence of gastrointestinal disorders is also anticipated to fuel the market over the forecast period.

North America Region Holds the Largest Market Share of Smart Pills Market

North America dominates the Smart Pills market, owing to factors such as technological advancements in the healthcare sector, an increase in the prevalence of colorectal cancer and regulatory approval of new products. All these factors are responsible to provide the growth opportunities for the players operating in this region.

Competitive Landscape

The market competition is set to intensify as several key players are focusing on the expansion of their Smart Pills portfolio through acquisition and collaboration with companies. The Smart Pills market is expected to open up several opportunities for new players as well as currently established market leaders.

Reasons to Purchase this report:

• The market estimate (ME) sheet in Excel format
• Report customization as per the client's requirements
• 3 months of analyst support

Table of Contents

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Preference for Minimally-invasive Device
  • 4.2.2 Increasing Incidence of Gastrointestinal Disorders
  • 4.2.3 Technological Advancements
• 4.3 Market Restraints
  • 4.3.1 Increasing Cost with Technological Advancements
  • 4.3.2 Potential Health Risks
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Application Area
  • 5.1.1 Capsule Endoscopy
    • 5.1.1.1 Small Bowel Video Capsule Endoscopy
    • 5.1.1.2 Colon Capsule Endoscopy
  • 5.1.2 Patient Monitoring
  • 5.1.3 Drug Delivery
• 5.2 By Disease Indication
  • 5.2.1 Occult GI Bleeding
  • 5.2.2 Crohn's Disease
  • 5.2.3 Small Bowel Tumors
  • 5.2.4 Celiac Disease
  • 5.2.5 Inherited Polyposis Syndromes
  • 5.2.6 Neurological Disorders
  • 5.2.7 Other Disease Indications
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 US
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 UK
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Boston Scientific Corporation
  • 6.1.2 GE Healthcare
  • 6.1.3 Given Imaging Ltd
  • 6.1.4 Microchips
  • 6.1.5 Novartis AG
  • 6.1.6 Olympus Medical Technology
  • 6.1.7 Phillips
  • 6.1.8 Pixie Scientific
  • 6.1.9 Proteus Pharmaceuticals
  • 6.1.10 Vitality

7 MARKET OPPORTUNITIES AND FUTURE TRENDS